Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Blood ; 105(11): 4353-61, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15705795

ABSTRACT

Matrix ligation of integrins alphavbeta3/alphavbeta5 is critical for endothelial survival and angiogenesis. We have previously shown that ceramide, a proapoptotic lipid second messenger, increases during endothelial anoikis (detachment-induced apoptosis). We now show that RGDfV, an integrin alphavbeta3/alphavbeta5 cyclic function-blocking peptide, increased ceramide and decreased sphingomyelin in human brain microvascular endothelial cells (HBMECs) plated on vitronectin, suggesting that sphingomyelin hydrolysis contributes to RGDfV-induced ceramide increase. Desipramine and imipramine, inhibitors of acid sphingomyelinase (ASMase), suppressed RGDfV-induced ceramide increase. Importantly, desipramine, imipramine, and a third ASMase inhibitor, SR33557, but not inhibitors of neutral sphingomyelinase, suppressed RGDfV-induced apoptosis, suggesting that ASMase was required for integrin-mediated apoptosis. Myriocin, an inhibitor of de novo ceramide synthesis, had no effect on RGDfV-induced HBMEC apoptosis. Interestingly, ASMase inhibitors also suppressed the RGDfV-induced loss of spreading on vitronectin. RGDfV induced a similar increase in ceramide and apoptosis in HBMECs on poly-l-lysine or vitronectin, although cells detached only from vitronectin, indicating that cell detachment was not required for RGDfV-induced apoptosis. Our results suggest involvement of ASMase and ceramide in endothelial apoptosis induced by inhibition of integrins alphavbeta3/alphavbeta5, and propose a novel molecular mechanism for the antiangiogenic effect of RGDfV.


Subject(s)
Apoptosis , Ceramides/metabolism , Endothelium, Vascular/cytology , Integrin alphaVbeta3/antagonists & inhibitors , Integrins/antagonists & inhibitors , Receptors, Vitronectin/antagonists & inhibitors , Angiogenesis Inhibitors/pharmacology , Brain/blood supply , Brain/cytology , Humans , Integrin alphaVbeta3/physiology , Integrins/physiology , Oligopeptides/pharmacology , Receptors, Vitronectin/physiology , Sphingomyelin Phosphodiesterase/antagonists & inhibitors , Sphingomyelin Phosphodiesterase/physiology , Sphingomyelins/metabolism
2.
J Biol Chem ; 277(51): 49531-7, 2002 Dec 20.
Article in English | MEDLINE | ID: mdl-12388538

ABSTRACT

Stress stimuli can mediate apoptosis by generation of the lipid second messenger, ceramide. Herein we investigate the molecular mechanism of ceramide signaling in endothelial apoptosis induced by fenretinide (N-(4-hydroxyphenyl)retinamide (4-HPR)). 4-HPR, a synthetic derivative of retinoic acid that induces ceramide in tumor cell lines, has been shown to have antiangiogenic effects, but the molecular mechanism of these is largely unknown. We report that 4-HPR was cytotoxic to endothelial cells (50% cytotoxicity at 2.4 microm, 90% at 5.36 microm) and induced a caspase-dependent endothelial apoptosis. 4-HPR (5 microm) increased ceramide levels in endothelial cells 5.3-fold, and the increase in ceramide was required to achieve the apoptotic effect of 4-HPR. The 4-HPR-induced increase in ceramide was suppressed by inhibitors of ceramide synthesis, fumonisin B(1), myriocin, and l-cycloserine, and 4-HPR transiently activated serine palmitoyltransferase, demonstrating that 4-HPR induced de novo ceramide synthesis. Sphingomyelin levels were not altered by 4-HPR, and desipramine had no effect on ceramide level, suggesting that sphingomyelinase did not contribute to the 4-HPR-induced ceramide increase. Finally, the pancaspase inhibitor, t-butyloxycarbonyl-aspartyl[O-methyl]-fluoromethyl ketone, suppressed 4-HPR-mediated apoptosis but not ceramide accumulation, suggesting that ceramide is upstream of caspases. Our results provide the first evidence that increased ceramide biosynthesis is required for 4-HPR-induced endothelial apoptosis and present a molecular mechanism for its antiangiogenic effects.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Ceramides/pharmacology , Endothelium, Vascular/pathology , Fenretinide/pharmacology , Signal Transduction , Acyltransferases/metabolism , Angiogenesis Inhibitors/pharmacology , Caspases/metabolism , Cells, Cultured , Ceramides/metabolism , Chromatography, High Pressure Liquid , Cycloserine/metabolism , Dose-Response Relationship, Drug , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Enzyme Activation , Fatty Acids, Monounsaturated/pharmacology , Flow Cytometry , G1 Phase , Glucosylceramides/metabolism , Humans , Microsomes , Reactive Oxygen Species , Resting Phase, Cell Cycle , Serine C-Palmitoyltransferase , Sphingomyelins/metabolism , Time Factors , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...